These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 17976741

  • 1. DNA vaccines encoding IL-2 linked to HPV-16 E7 antigen generate enhanced E7-specific CTL responses and antitumor activity.
    Lin CT, Tsai YC, He L, Yeh CN, Chang TC, Soong YK, Monie A, Hung CF, Lai CH.
    Immunol Lett; 2007 Dec 15; 114(2):86-93. PubMed ID: 17976741
    [Abstract] [Full Text] [Related]

  • 2. Enhanced therapeutic effects conferred by an experimental DNA vaccine targeting human papillomavirus-induced tumors.
    Diniz MO, Cariri FA, Aps LR, Ferreira LC.
    Hum Gene Ther; 2013 Oct 15; 24(10):861-70. PubMed ID: 24007495
    [Abstract] [Full Text] [Related]

  • 3. Enhancement of therapeutic DNA vaccine potency by melatonin through inhibiting VEGF expression and induction of antitumor immunity mediated by CD8+ T cells.
    Baghban Rahimi S, Mohebbi A, Vakilzadeh G, Biglari P, Razeghi Jahromi S, Mohebi SR, Shirian S, Gorji A, Ghaemi A.
    Arch Virol; 2018 Mar 15; 163(3):587-597. PubMed ID: 29149434
    [Abstract] [Full Text] [Related]

  • 4. [Linkage of modified human papillomavirus type 16 E7 to CD40 ligand enhances specific CD8+ T-lymphocyte induction and anti-tumour activity of DNA vaccine].
    Wang QY, Xu YF, Fan DS, Peng QL, Zhang T, Xu XM.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2007 Oct 15; 29(5):584-91. PubMed ID: 18051710
    [Abstract] [Full Text] [Related]

  • 5. Immune responses and therapeutic antitumor effects of an experimental DNA vaccine encoding human papillomavirus type 16 oncoproteins genetically fused to herpesvirus glycoprotein D.
    Diniz MO, Lasaro MO, Ertl HC, Ferreira LC.
    Clin Vaccine Immunol; 2010 Oct 15; 17(10):1576-83. PubMed ID: 20739505
    [Abstract] [Full Text] [Related]

  • 6. Rational design of DNA vaccines for the induction of human papillomavirus type 16 E6- and E7-specific cytotoxic T-cell responses.
    Oosterhuis K, Aleyd E, Vrijland K, Schumacher TN, Haanen JB.
    Hum Gene Ther; 2012 Dec 15; 23(12):1301-12. PubMed ID: 22971245
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Different domains of glycoprotein 96 influence HPV16 E7 DNA vaccine potency via electroporation mediated delivery in tumor mice model.
    Daemi A, Bolhassani A, Rafati S, Zahedifard F, Hosseinzadeh S, Doustdari F.
    Immunol Lett; 2012 Dec 17; 148(2):117-25. PubMed ID: 23085605
    [Abstract] [Full Text] [Related]

  • 10. Suppression of antitumour protective cytotoxic T lymphocyte responses to a human papillomavirus 16 E7 DNA vaccine by coinjection of interleukin-12 complementary DNA: involvement of nitric oxide in immune suppression.
    Sin JI.
    Immunology; 2009 Sep 17; 128(1 Suppl):e707-17. PubMed ID: 19740332
    [Abstract] [Full Text] [Related]

  • 11. DNA vaccine encoding HPV-16 E7 with mutation in L-Y-C-Y-E pRb-binding motif induces potent anti-tumor responses in mice.
    Bahrami AA, Ghaemi A, Tabarraei A, Sajadian A, Gorji A, Soleimanjahi H.
    J Virol Methods; 2014 Sep 17; 206():12-8. PubMed ID: 24880067
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A novel self-assembled nanoparticle vaccine with HIV-1 Tat₄₉₋₅₇/HPV16 E7₄₉₋₅₇ fusion peptide and GM-CSF DNA elicits potent and prolonged CD8⁺ T cell-dependent anti-tumor immunity in mice.
    Tang J, Yin R, Tian Y, Huang Z, Shi J, Fu X, Wang L, Wu Y, Hao F, Ni B.
    Vaccine; 2012 Feb 01; 30(6):1071-82. PubMed ID: 22178528
    [Abstract] [Full Text] [Related]

  • 14. Histone deacetylase inhibitor AR-42 enhances E7-specific CD8⁺ T cell-mediated antitumor immunity induced by therapeutic HPV DNA vaccination.
    Lee SY, Huang Z, Kang TH, Soong RS, Knoff J, Axenfeld E, Wang C, Alvarez RD, Chen CS, Hung CF, Wu TC.
    J Mol Med (Berl); 2013 Oct 01; 91(10):1221-31. PubMed ID: 23715898
    [Abstract] [Full Text] [Related]

  • 15. Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen.
    Hung CF, Cheng WF, Hsu KF, Chai CY, He L, Ling M, Wu TC.
    Cancer Res; 2001 May 01; 61(9):3698-703. PubMed ID: 11325841
    [Abstract] [Full Text] [Related]

  • 16. Immunological responses and anti-tumor effects of HPV16/18 L1-L2-E7 multiepitope fusion construct along with curcumin and nanocurcumin in C57BL/6 mouse model.
    Kayyal M, Bolhassani A, Noormohammadi Z, Sadeghizadeh M.
    Life Sci; 2021 Nov 15; 285():119945. PubMed ID: 34516991
    [Abstract] [Full Text] [Related]

  • 17. Antitumor Immunity Induced by Genetic Immunization with Chitosan Nanoparticle Formulated Adjuvanted for HPV-16 E7 DNA Vaccine.
    Tahamtan A, Barati M, Tabarraei A, Mohebbi SR, Shirian S, Gorji A, Ghaemi A.
    Iran J Immunol; 2018 Dec 15; 15(4):269-280. PubMed ID: 30593741
    [Abstract] [Full Text] [Related]

  • 18. Enhancement of DNA vaccine potency by linkage of antigen gene to a gene encoding the extracellular domain of Fms-like tyrosine kinase 3-ligand.
    Hung CF, Hsu KF, Cheng WF, Chai CY, He L, Ling M, Wu TC.
    Cancer Res; 2001 Feb 01; 61(3):1080-8. PubMed ID: 11221836
    [Abstract] [Full Text] [Related]

  • 19. Expression of a soluble IL-10 receptor enhances the therapeutic effects of a papillomavirus-associated antitumor vaccine in a murine model.
    Silva JR, Sales NS, Silva MO, Aps LRMM, Moreno ACR, Rodrigues EG, Ferreira LCS, Diniz MO.
    Cancer Immunol Immunother; 2019 May 01; 68(5):753-763. PubMed ID: 30806747
    [Abstract] [Full Text] [Related]

  • 20. MyD88 signal is required for more efficient induction of Ag-specific adaptive immune responses and antitumor resistance in a human papillomavirus E7 DNA vaccine model.
    Sin JI.
    Vaccine; 2011 May 31; 29(24):4125-31. PubMed ID: 21496466
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.